REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 135 filers reported holding REVOLUTION MEDICINES INC in Q4 2022. The put-call ratio across all filers is 0.32 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $38,210,377 | -46.2% | 1,604,130 | -55.5% | 29.95% | -3.5% |
| Q3 2022 | $71,073,000 | -28.6% | 3,604,130 | -29.4% | 31.03% | -23.7% |
| Q2 2022 | $99,479,000 | -29.4% | 5,104,130 | -7.6% | 40.69% | +6.4% |
| Q1 2022 | $140,918,000 | +1.4% | 5,524,031 | 0.0% | 38.24% | +9.9% |
| Q4 2021 | $139,040,000 | -8.5% | 5,524,031 | 0.0% | 34.79% | +20.6% |
| Q3 2021 | $151,966,000 | -13.3% | 5,524,031 | 0.0% | 28.85% | -5.8% |
| Q2 2021 | $175,333,000 | -30.8% | 5,524,031 | 0.0% | 30.61% | -4.5% |
| Q1 2021 | $253,443,000 | -8.9% | 5,524,031 | -21.4% | 32.06% | +34.2% |
| Q4 2020 | $278,081,000 | -0.4% | 7,024,031 | -12.5% | 23.88% | +1.8% |
| Q3 2020 | $279,236,000 | -2.0% | 8,024,031 | -11.1% | 23.46% | -43.6% |
| Q2 2020 | $284,889,000 | +44.1% | 9,024,031 | 0.0% | 41.58% | -22.7% |
| Q1 2020 | $197,717,000 | – | 9,024,031 | – | 53.79% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,524,031 | $151,966,000 | 28.85% |
| Ponoi II Management, LLC | 685,011 | $18,845,000 | 27.92% |
| Ponoi Management, LLC | 685,011 | $18,845,000 | 16.73% |
| Column Group LLC | 3,347,245 | $92,083,000 | 10.48% |
| TRV GP IV, LLC | 1,419,900 | $39,061,000 | 8.86% |
| Cormorant Asset Management, LP | 3,144,700 | $86,511,000 | 3.52% |
| Boxer Capital, LLC | 3,484,264 | $95,852,000 | 3.35% |
| BVF INC/IL | 2,485,049 | $68,364,000 | 2.67% |
| Casdin Capital, LLC | 2,800,000 | $77,028,000 | 1.92% |
| COMMODORE CAPITAL LP | 226,228 | $6,224,000 | 1.64% |